# Ziarco Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ziarco-group

- Industry: Biotechnology
- Headquarters: Sandwich, UK
- Website: www.ziarcopharma.com
- Total disclosed funding: $41M
- Latest round: Series B (Nov 10, 2014)
- Investors on record: 5

## About

Founded in 2012 and based in Sandwich, UK, Ziarco Group Limited is a clinical stage biotechnology company developing therapies for inflammatory and allergic diseases.

## Funding rounds

- Series B, Nov 10, 2014, $33M — New Enterprise Associates, Amgen Ventures, Lundbeckfond Ventures, Pfizer Venture Investments, BVF Partners
- Series A, Oct 30, 2012, $7.6M — Pfizer Venture Investments, BVF Partners

## Investors

- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series A, Series B
- BVF Partners (https://capitalatlas.ai/funds/bvf-partners) — Series A, Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series B
- Lundbeckfond Ventures (https://capitalatlas.ai/funds/lundbeckfond-ventures) — Series B